Enforcement intelligence for promotional review
FDA is using AI to find non-compliant drug ads. Use AI to prevent them.
Net Impression turns every public FDA OPDP untitled letter into a searchable, precedent-backed guardrail — so promotional reviewers and launch teams see what actually draws a letter before marketing does.
Untitled letters issued per year
13×jump from 2024 → 2025
2
17
5
18
7
19
2
20
4
21
3
22
4
23
5
24
63
25
19
26
5 letters in 2024 → 63 in 2025. A 2025-09-09 presidential memorandum triggered a mass drop of ~40 letters in a single day.
114
Untitled letters
79+
Companies cited
274
Extracted findings
22
Neuroscience letters
Your organization is in the corpus
Takeda received 3 untitled letters — all 3 on a single day (Sept 9, 2025)
Claim Checker
Paste a promotional claim. Get every FDA precedent that resembles it, a risk read, and a compliant rewrite.
Test a claim →
Enforcement Explorer
Month-over-month enforcement, filterable by therapeutic area, company, channel, and violation.
Open explorer →
Ask Net Impression
Ask in plain English — 'was there action on a TV ad?' — with voice. Every answer cites real letters.
Start asking →